• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

突触生物标志物在神经退行性疾病谱中的作用。

The role of synaptic biomarkers in the spectrum of neurodegenerative diseases.

机构信息

Department of Clinical and Experimental Medicine, University of Pisa , Pisa, Italy.

Sorbonne University, GRC N° 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de L'hôpital , Paris, France.

出版信息

Expert Rev Proteomics. 2020 Jul-Aug;17(7-8):543-559. doi: 10.1080/14789450.2020.1831388. Epub 2020 Oct 18.

DOI:10.1080/14789450.2020.1831388
PMID:33028119
Abstract

INTRODUCTION

The quest for reliable fluid biomarkers tracking synaptic disruption is supported by the evidence of a tight association between synaptic density and cognitive performance in neurodegenerative diseases (NDD), especially Alzheimer's disease (AD).

AREAS COVERED

Neurogranin (Ng) is a post-synaptic protein largely expressed in neurons involved in the memory networks. Currently, Ng measured in CSF is the most promising synaptic biomarker. Several studies show Ng elevated in AD dementia with a hippocampal phenotype as well as in MCI individuals who progress to AD. Ng concentrations are also increased in Creutzfeldt Jacob Disease where widespread and massive synaptic disintegration takes place. Ng does not discriminate Parkinson's disease from atypical parkinsonisms, nor is it altered in Huntington disease. CSF synaptosomal-associated protein 25 (SNAP-25) and synaptotagmin-1 (SYT-1) are emerging candidates.

EXPERT OPINION

CSF Ng revealed a role as a diagnostic and prognostic biomarker in NDD. Ng increase seems to be very specific for typical AD phenotype, probably for a prevalent hippocampal involvement. Synaptic biomarkers may serve different context-of-use in AD and other NDD including prognosis, diagnosis, and tracking synaptic damage - a critical pathophysiological mechanism in NDD - thus representing reliable tools for a precision medicine-oriented approach to NDD.

摘要

简介

有证据表明,在神经退行性疾病(NDD)中,尤其是在阿尔茨海默病(AD)中,突触密度与认知表现密切相关,这为寻找可靠的流体生物标志物来跟踪突触功能障碍提供了依据。

涵盖领域

神经颗粒蛋白(Ng)是一种主要表达在参与记忆网络的神经元中的突触后蛋白。目前,脑脊液中的 Ng 是最有前途的突触生物标志物。多项研究表明,AD 痴呆患者(伴有海马表型)和进展为 AD 的轻度认知障碍(MCI)患者的脑脊液 Ng 升高。在广泛而大量的突触解体的克雅氏病(Creutzfeldt Jacob Disease)中,Ng 浓度也会增加。Ng 不能区分帕金森病和非典型帕金森病,也不会在亨廷顿病中改变。脑脊液突触体相关蛋白 25(SNAP-25)和突触结合蛋白-1(SYT-1)是新兴的候选标志物。

专家意见

脑脊液 Ng 被揭示为 NDD 的一种诊断和预后生物标志物。Ng 的增加似乎对典型的 AD 表型非常特异,可能与普遍的海马受累有关。突触生物标志物在 AD 和其他 NDD 中可能具有不同的用途,包括预后、诊断和跟踪突触损伤——这是 NDD 的一个关键病理生理机制——因此,它们是针对 NDD 的精准医疗方法的可靠工具。

相似文献

1
The role of synaptic biomarkers in the spectrum of neurodegenerative diseases.突触生物标志物在神经退行性疾病谱中的作用。
Expert Rev Proteomics. 2020 Jul-Aug;17(7-8):543-559. doi: 10.1080/14789450.2020.1831388. Epub 2020 Oct 18.
2
CSF synaptic protein concentrations are raised in those with atypical Alzheimer's disease but not frontotemporal dementia.脑脊液突触蛋白浓度在非典型性阿尔茨海默病患者中升高,但在额颞叶痴呆患者中不升高。
Alzheimers Res Ther. 2019 Dec 17;11(1):105. doi: 10.1186/s13195-019-0564-2.
3
Increased levels of the synaptic proteins PSD-95, SNAP-25, and neurogranin in the cerebrospinal fluid of patients with Alzheimer's disease.阿尔茨海默病患者脑脊液中突触蛋白 PSD-95、SNAP-25 和神经颗粒蛋白水平升高。
Alzheimers Res Ther. 2022 Apr 23;14(1):58. doi: 10.1186/s13195-022-01002-x.
4
Dissection of synaptic pathways through the CSF biomarkers for predicting Alzheimer disease.通过脑脊液生物标志物对突触通路进行解剖,以预测阿尔茨海默病。
Neurology. 2020 Aug 25;95(8):e953-e961. doi: 10.1212/WNL.0000000000010131. Epub 2020 Jun 25.
5
Neurogranin as biomarker in CSF is non-specific to Alzheimer's disease dementia.神经颗粒蛋白作为脑脊液中的生物标志物,对阿尔茨海默病痴呆是非特异性的。
Neurobiol Aging. 2021 Dec;108:99-109. doi: 10.1016/j.neurobiolaging.2021.08.002. Epub 2021 Aug 8.
6
Increased neurogranin concentrations in cerebrospinal fluid of Alzheimer's disease and in mild cognitive impairment due to AD.阿尔茨海默病及由其导致的轻度认知障碍患者脑脊液中神经颗粒素浓度升高。
J Neural Transm (Vienna). 2016 Dec;123(12):1443-1447. doi: 10.1007/s00702-016-1597-3. Epub 2016 Aug 16.
7
CSF neurogranin as a neuronal damage marker in CJD: a comparative study with AD.脑脊液神经颗粒蛋白作为 CJD 的神经元损伤标志物:与 AD 的比较研究。
J Neurol Neurosurg Psychiatry. 2019 Aug;90(8):846-853. doi: 10.1136/jnnp-2018-320155. Epub 2019 May 16.
8
Diagnostic and prognostic value of cerebrospinal fluid SNAP-25 and neurogranin in Creutzfeldt-Jakob disease in a clinical setting cohort of rapidly progressive dementias.在快速进展性痴呆的临床队列中,脑脊液 SNAP-25 和神经颗粒蛋白在克雅氏病中的诊断和预后价值。
Alzheimers Res Ther. 2023 Sep 8;15(1):150. doi: 10.1186/s13195-023-01300-y.
9
Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's disease.常染色体显性阿尔茨海默病中新兴的脑脊液生物标志物。
Alzheimers Dement. 2019 May;15(5):655-665. doi: 10.1016/j.jalz.2018.12.019. Epub 2019 Mar 4.
10
Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology.神经退行性变中脑脊液神经颗粒蛋白浓度:与临床表型和神经病理学的关系。
Acta Neuropathol. 2018 Sep;136(3):363-376. doi: 10.1007/s00401-018-1851-x. Epub 2018 Apr 26.

引用本文的文献

1
The Cooperation of Neurogranin with Calmodulin Promotes the Treatment of Aging-Related Diseases via Regular Exercise.神经颗粒素与钙调蛋白的协同作用通过规律运动促进衰老相关疾病的治疗。
Mol Neurobiol. 2025 Apr 26. doi: 10.1007/s12035-025-04959-6.
2
Growth associated protein 43 (GAP-43) predicts brain amyloidosis in Alzheimer's dementia continuum: an [ F] AV-45 study.生长相关蛋白43(GAP - 43)在阿尔茨海默病痴呆连续体中预测脑淀粉样变性:一项[F] AV - 45研究。
BMC Neurol. 2025 Apr 1;25(1):134. doi: 10.1186/s12883-025-04140-5.
3
Maternal immune activation imprints translational dysregulation and differential MAP2 phosphorylation in descendant neural stem cells.
母体免疫激活会在后代神经干细胞中留下翻译失调和微管相关蛋白2(MAP2)磷酸化差异的印记。
Mol Psychiatry. 2025 Feb 3. doi: 10.1038/s41380-025-02905-5.
4
Delivering synaptic protein mRNAs via extracellular vesicles ameliorates cognitive impairment in a mouse model of Alzheimer's disease.通过细胞外囊泡传递突触蛋白 mRNAs 可改善阿尔茨海默病小鼠模型的认知障碍。
BMC Med. 2024 Mar 25;22(1):138. doi: 10.1186/s12916-024-03359-2.
5
Diagnostic and prognostic value of cerebrospinal fluid SNAP-25 and neurogranin in Creutzfeldt-Jakob disease in a clinical setting cohort of rapidly progressive dementias.在快速进展性痴呆的临床队列中,脑脊液 SNAP-25 和神经颗粒蛋白在克雅氏病中的诊断和预后价值。
Alzheimers Res Ther. 2023 Sep 8;15(1):150. doi: 10.1186/s13195-023-01300-y.
6
Identification of key genes and signaling pathways associated with dementia with Lewy bodies and Parkinson's disease dementia using bioinformatics.运用生物信息学鉴定与路易体痴呆和帕金森病痴呆相关的关键基因及信号通路。
Front Neurol. 2023 Mar 9;14:1029370. doi: 10.3389/fneur.2023.1029370. eCollection 2023.
7
Linking the Amyloid, Tau, and Mitochondrial Hypotheses of Alzheimer's Disease and Identifying Promising Drug Targets.将阿尔茨海默病的淀粉样蛋白、tau 和线粒体假说联系起来,并确定有前途的药物靶点。
Biomolecules. 2022 Nov 11;12(11):1676. doi: 10.3390/biom12111676.
8
[Prognostic and diagnostic value of cerebrospinal fluid analysis in neurodegenerative dementia diseases].[脑脊液分析在神经退行性痴呆疾病中的预后和诊断价值]
Nervenarzt. 2022 Dec;93(12):1236-1242. doi: 10.1007/s00115-022-01339-6. Epub 2022 Jun 7.
9
Fluid Biomarkers in Alzheimer's Disease and Other Neurodegenerative Disorders: Toward Integrative Diagnostic Frameworks and Tailored Treatments.阿尔茨海默病及其他神经退行性疾病中的流体生物标志物:迈向综合诊断框架与个性化治疗
Diagnostics (Basel). 2022 Mar 24;12(4):796. doi: 10.3390/diagnostics12040796.
10
Neurofilament Levels Are Reflecting the Loss of Presynaptic Dopamine Receptors in Movement Disorders.神经丝水平反映了运动障碍中突触前多巴胺受体的丧失。
Front Neurosci. 2021 Dec 3;15:690013. doi: 10.3389/fnins.2021.690013. eCollection 2021.